Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine

Špaček, M.; Obrtlíková, P.; Hadrabová,  Markéta; Cmunt,  Eduard; Karban, J.; Molinský, J.; Simkovic, M.; Móciková,  Heidi; Mohammadova, L.; Panovská,  Anna; Novák, J.; Smolej,  Lukáš; Doubek,  Michael; Trněný,  Marek

Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	ŠPAČEK M. OBRTLÍKOVÁ P. HADRABOVÁ Markéta CMUNT Eduard KARBAN J. MOLINSKÝ J. SIMKOVIC M. MÓCIKOVÁ Heidi MOHAMMADOVA L. PANOVSKÁ Anna NOVÁK J. SMOLEJ Lukáš DOUBEK Michael TRNĚNÝ Marek
Year of publication	2017
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine, Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine
Related projects:	MEDGENET - Medical genomics and epigenomics network